OC-0372: DAHANCA19: A randomized phase III study of primary (chemo-) radiotherapy and zalutumumab in head and neck carcinomasJ.G. Eriksen,C. Maare,J. Johansen, H. Primdahl, J. Evensen,C.A. Kristensen, L.J. Andersen,J. OvergaardRadiotherapy and Oncology（2014）引用 4|浏览10暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
